Tag: Chief

Jennie Orr Appointed Chief Strategy and Business Officer at Camargo Pharmaceutical Services, LLC

CINCINNATI, Oct. 13, 2020 /PRNewswire/ — Camargo Pharmaceutical Services, LLC, a global drug development and commercial partner, announced today the appointment of Jennie Orr as Chief Strategy and Business Officer. In this newly created senior leadership role, Orr will lead the development, communication and execution of corporate strategic growth initiatives including both organic growth and its mergers and acquisitions activities.

“Jennie has consistently demonstrated her strong leadership abilities and her dedication to Camargo’s values since she joined us in 2018,” Camargo CEO Dan Duffy said. “Having her in this position will enable us to advance our operational vision and achieve our growth expectations for the future.”

Camargo is a leading global strategy, regulatory and commercial partner for emerging and mid-size biopharma companies and has been instrumental in helping numerous pharmaceutical companies identify opportunities, develop products and obtain FDA approvals. Its work in orphan drugs, improved drugs, oncology and many

Read More

Erie economic development chief has a ‘passion’ for community service

Kevin Flowers
 
| Erie Times-News
play

Debra Smith never thought about making history.

When Smith began working for the city of Erie as an employment and training accountant in December 1985, the Erie native and Indiana University of Pennsylvania graduate was happy to have found a steady job working with numbers.

She figured that her time with city government would eventually lead to a career as a certified public accountant. 

Later, she began crunching the numbers for a number of city economic and community development initiatives, and that’s when things changed. 

Smith started to comprehend the humanity represented in those ledgers, reports and spreadsheets — and realized she wanted to do even more. 

“I was dealing with Community

Read More

A chief investment strategist explains why making short-term bets ahead of the election is a risky strategy



a man talking on a cell phone: Johannes Eisele/Getty Images


© Johannes Eisele/Getty Images
Johannes Eisele/Getty Images

  • A Charles Schwab chief investment strategist explained why making short-term bets ahead of the election is a risky strategy.
  • In the span of the last 30 election cycles, there have been a range of significant impacts on market performance that had “little-to-no relationship” with the incumbent party in the White House, the strategist, Liz Ann Sonders, noted.
  • Considering the multitude of market outcomes in every election cycle, she said “the economy impacts elections more than elections impact the economy.”
  • Investors looking for clear connections between the election and market performance cannot expect easy answers, she said.
  • Visit Business Insider’s homepage for more stories.

Betting on election outcomes is risky as history makes it clear that the relationship between politics and the stock market is varied and absent of consistency, according to a chief investment strategist at Charles Schwab, Liz Ann Sonders.

Loading...

Load Error

Read More

Wall Street strategy chief says the market is flashing bullish signals as more stocks start to rally


  • Miller Tabak’s chief market strategist told CNBC on Friday the stock market is signaling it has upside potential before Election Day. 
  • Matt Maley cited the outperformance of the Russell 2000 index and said small-cap stocks and chip stocks have room to grow. 
  • He’s less optimistic about the market in the long term, however. A second wave of the coronavirus and an expensive market could be bearish after the election, he said. 

Matt Maley of Miller Tabak  told CNBC on Friday that the stock market is signaling it has upside potential before Election Day.

The chief market strategist said he is watching the recent outperformance of small-cap stocks. As of Thursday, the Russell 2000 small-cap index was up almost 6% week-to-date, compared to a roughly 3% gain in the S&P 500. The broadening out of the stock market rally, which was previously dominated by mega-cap tech names, is

Read More

A Wall Street strategy chief says the market is flashing bullish signals as more stocks start to rally



a man wearing a suit and tie: CNBC TV


© CNBC TV
CNBC TV

  • Miller Tabak’s chief market strategist told CNBC on Friday the stock market is signaling it has upside potential before Election Day. 
  • Matt Maley cited the outperformance of the Russell 2000 index and said small-cap stocks and chip stocks have room to grow. 
  • He’s less optimistic about the market in the long term, however. A second wave of the coronavirus and an expensive market could be bearish after the election, he said. 

Matt Maley of Miller Tabak  told CNBC on Friday that the stock market is signaling it has upside potential before Election Day.

Loading...

Load Error

The chief market strategist said he is watching the recent outperformance of small-cap stocks. As of Thursday, the Russell 2000 small-cap index was up almost 6% week-to-date, compared to a roughly 3% gain in the S&P 500. The broadening out of the stock market rally, which was previously dominated by

Read More

Ludovic Blanquet Joins smartTrade as Chief Product and Strategic Planning Officer

LONDON & AIX-EN-PROVENCE, France–(BUSINESS WIRE)–smartTrade Technologies today announces that Ludovic Blanquet has joined as Chief Product and Strategic Planning Officer. Ludovic will support smartTrade to deliver world class integrated eTrading solutions.

Ludovic brings 20 years of industry experience to the role. He joins from Finastra where he was the Global Head of Product Strategy across its five lines of business. Prior to this, he built Credit Agricole APAC’s global equities trading platform and was APAC regional director for SmartStream, a corporate banking software vendor. Ludovic has experience working across multiple international markets having lived in Tokyo, London and Singapore during his career.

Ludovic will help shape smartTrade’s vision to deliver the leading cross-asset eTrading solution, capitalising on its market leading eFX LiquidityFX (LFX) cloud offering. Now based in London, Ludovic will lead a team of strategy and product managers responsible for designing and delivering on the future product

Read More

EEI Corporation: Digital transformation in construction | Business Chief APAC

NORWICH, England, Oct. 8, 2020 /PRNewswire/ — BizClik Media Group (BMG), announced today the release of Business Chief APAC October 2020 edition.

October’s cover features Lauro Matias, CIO of EEI Corporation. Matias discusses the technologies involved in its digital transformation, as well as its response to COVID-19. “For me, digital business strategy is about the extension of a company’s physical reality and capabilities using digital technology,” comments Matias.

In addition to Matias, we speak to Alan Chiew, Executive Director and Head of Technology, Digital Channels at Standard Chartered Bank; James Haslam, CFO at ELMO Cloud HR & Payroll; and Andrew Duncan, Partner and UK Head at Infosys Consulting.

“As the pandemic continues to disrupt operations and objectives, the skills required to maintain business continuity are likely to remain in flux. Consequently, we will need to equip our employees with an all-purpose skill set – one

Read More

Hyde Engineering + Consulting Announces Appointment of Chief Operating Officer

BOULDER, Colo., Oct. 7, 2020 /PRNewswire/ — Hyde Engineering + Consulting, Inc. (Hyde) a worldwide partner for solution-based pharmaceutical design and consultant services, announced the appointment of Kalpesh Patel as Chief Operating Officer (COO).  Patel will lead Hyde’s growing global enterprise, translating the growth strategies set by Hyde’s Board of Directors and CEO to maximize profitability.

“I’m embracing this role with the focused calm and practical ideology that led me here. As I accept this new challenge, I will be relying on my extremely capable colleagues to work towards Hyde’s global integration, focusing on the consistency of operational processes and efficient utilization of our combined talents. I’m sincerely honored to be selected into this role and will put forth my best efforts to maintain company culture and sustainability, expanding that to Hyde’s global entity,” Kalpesh Patel, COO.

“From first joining the company in 2005, Kalpesh has been and

Read More

Jennifer Johnson Joins Amplitude as First-Ever Chief Marketing and Strategy Officer

SAN FRANCISCO, Oct. 07, 2020 (GLOBE NEWSWIRE) — Amplitude, the global leader in product intelligence, today appointed enterprise software marketing and category designer veteran Jennifer Johnson, former chief marketing officer (CMO) at Tenable (Nasdaq: TENB), as the company’s first-ever chief marketing and strategy officer. In this newly created role, Johnson will spearhead Amplitude’s corporate and marketing strategy to lead the company through its next phase of growth and redefine how digital organizations–big and small–adopt product intelligence.

Johnson is a three-time powerhouse enterprise software CMO, well-known for innovation, creativity, and propelling disruptive companies into defining, transforming and leading market categories. Most recently, she was the first-ever CMO at Tenable, one of the most respected brands in cybersecurity, and played an instrumental role in the company’s successful IPO in 2018. Previously, Johnson served as Tanium’s first-ever CMO, leading the company through consecutive years of triple-digit hypergrowth. Before Tanium, Johnson was CMO

Read More

Polyneuron Appoints Aled Williams as Chief Business Officer

Polyneuron Pharmaceuticals AG, a clinical stage developer of a new class of antigen-specific polymers for the treatment of patients with serious autoimmune diseases, today announced the appointment of Aled Williams as Chief Business Officer. Mr Williams joins Polyneuron with more than 25 years’ of leadership experience in the pharmaceutical industry, with a recent focus on developing and commercialising rare disease therapeutics.

“Aled has extensive leadership experience across functions and therapeutic areas in both the pharmaceutical and biotech sectors. We believe this expertise makes him the perfect choice to lead our corporate strategy and business development efforts,” said Ruben Herrendorff, Ph.D., CEO and co-founder of Polyneuron.

Mr Williams most recently held chief commercial officer positions at VectivBio and Therachon. As a member of the Executive team at Therachon, he played a key role in the acquisition of GLyPharma Therapeutic, which expanded Therachon’s rare disease portfolio, and the subsequent acquisition of Therachon

Read More